Takeda Pharmaceutical Co., Ltd. (TKPHF)
37.88
+1.44
(+3.96%)
USD |
OTCM |
Aug 25, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 59.86B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 27.25% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 2.016 |
| Price to Book Value | 1.287 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.6407 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.6536 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 48.11% |
Profile
| Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following business divisions: Gastrointestinal Diseases, Rare Diseases, Plasma-Derived Therapies, Oncology, Vaccines, and Neuroscience The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. |
| URL | http://www.takeda.com |
| Investor Relations URL | https://www.takeda.com/investors |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Mid Cap Value |
| Next Earnings Release | Oct. 29, 2026 |
| Last Earnings Release | Jul. 30, 2026 |
| Next Ex-Dividend Date | Sep. 30, 2026 |
| Last Ex-Dividend Date | Mar. 31, 2026 |
Profile
| Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following business divisions: Gastrointestinal Diseases, Rare Diseases, Plasma-Derived Therapies, Oncology, Vaccines, and Neuroscience The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. |
| URL | http://www.takeda.com |
| Investor Relations URL | https://www.takeda.com/investors |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Mid Cap Value |
| Next Earnings Release | Oct. 29, 2026 |
| Last Earnings Release | Jul. 30, 2026 |
| Next Ex-Dividend Date | Sep. 30, 2026 |
| Last Ex-Dividend Date | Mar. 31, 2026 |